A Study to Assess Safety, Tolerability, PK and PD of AZD2693 in Non-alcoholic Steatohepatitis Patients

NCT04483947 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-alcoholic Steatohepatitis (NASH)

Interventions

DRUG: AZD2693
OTHER: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]